Platform Potential

A revolutionary shift in the pharma industry is explored, highlighting how mRNA technology allows for a platform approach, akin to a modular toy. This method presents both opportunities and challenges, especially when it comes to attracting investment and communicating potential to stakeholders. The conversation emphasizes the importance of patience and strategic focus in building a robust platform for future innovations.